Free Shipping on Orders Above ₹399 | Shop Now & Save More
Telma-LNβ 25 Tablets
-11%
₹ 170.21 ₹ 191.25 -11%
SKU
Telma-LNβ 25 Tablets contain Telmisartan IP 40 mg, Cilnidipine IP 10 mg, and Metoprolol Succinate IP 23.75 mg (equivalent to Metoprolol Tartrate 25 mg). This triple-combination prescription medicine is used for the management of hypertension (high blood pressure) in suitable patients requiring combination therapy. Its active ingredients work through complementary mechanisms to help relax blood vessels, regulate heart rate, and support effective blood pressure control. Use only as prescribed by a registered medical practitioner.
- Contains Telmisartan IP 40 mg
- Contains Cilnidipine IP 10 mg
- Contains Metoprolol Succinate IP 23.75 mg (equivalent to Metoprolol Tartrate 25 mg)
- Triple-combination therapy for hypertension management
- Helps relax blood vessels and support improved blood flow
- Metoprolol helps regulate heart rate and reduce cardiac workload
- Prescription-only medicine for use under medical supervision
- Take exactly as prescribed by your physician.
- Swallow the tablet whole with water.
- Do not crush or chew the tablet, particularly because it contains an extended-release component.
- Take the medicine at the same time each day as advised by your doctor.
- Do not change the dose or stop treatment suddenly without consulting your physician.
- Monitor your blood pressure and heart rate as recommended by your healthcare professional.
- Telmisartan IP: 40 mg
- Cilnidipine IP: 10 mg
- Metoprolol Succinate IP: 23.75 mg (equivalent to Metoprolol Tartrate 25 mg)
- Release Type: Extended Release (Metoprolol component)
- Colours: Sunset Yellow Lake & Titanium Dioxide IP
- Excipients: q.s.
- Dosage Form: Tablet
- Category: Schedule H Prescription Medicine
- Manufacturer/Marketer: Glenmark Pharmaceuticals Ltd.
- Store below 30°C, protected from light and moisture.
- Keep out of reach of children.
- Keep tablets in the original blister strip until ready to use.
- Use only under the supervision of a registered medical practitioner.
- Inform your doctor if you have heart, kidney, liver, circulation, or breathing-related conditions.
- Inform your doctor immediately if pregnancy occurs. Telmisartan-containing medicines can cause fetal harm and require prompt medical review.
- This medicine may cause dizziness or lightheadedness in some people; avoid driving or operating machinery if affected.
- Do not stop Metoprolol-containing treatment suddenly unless specifically advised by your physician.
- Do not use after the expiry date printed on the pack.
This is a Schedule H prescription medicine. Information provided is for educational and product listing purposes only and does not replace professional medical advice. Always use this medicine under the supervision of a registered medical practitioner and follow the prescribed dosage, product label, and package insert carefully. Product details and packaging may vary according to manufacturer updates.
Customers albo bought
